US3814769A - Catalyzed radioiodine exchange - Google Patents

Catalyzed radioiodine exchange Download PDF

Info

Publication number
US3814769A
US3814769A US00212662A US21266271A US3814769A US 3814769 A US3814769 A US 3814769A US 00212662 A US00212662 A US 00212662A US 21266271 A US21266271 A US 21266271A US 3814769 A US3814769 A US 3814769A
Authority
US
United States
Prior art keywords
copper
iodine
exchange
compounds
iodine atoms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US00212662A
Inventor
G Hoey
D Peckels
P Wiegert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mallinckrodt Inc
Mallinckrodt Chemical Works
Original Assignee
Mallinckrodt Chemical Works
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Chemical Works filed Critical Mallinckrodt Chemical Works
Priority to US00212662A priority Critical patent/US3814769A/en
Application granted granted Critical
Publication of US3814769A publication Critical patent/US3814769A/en
Assigned to MALLINCKRODT, INC. reassignment MALLINCKRODT, INC. CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: MALCO, INC.
Assigned to MALLINCKRODT MEDICAL, INC., A DE CORP. reassignment MALLINCKRODT MEDICAL, INC., A DE CORP. ASSIGNMENT OF ASSIGNORS INTEREST. Assignors: MALLINCKRODT, INC., A CORP. OF DE
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G21NUCLEAR PHYSICS; NUCLEAR ENGINEERING
    • G21HOBTAINING ENERGY FROM RADIOACTIVE SOURCES; APPLICATIONS OF RADIATION FROM RADIOACTIVE SOURCES, NOT OTHERWISE PROVIDED FOR; UTILISING COSMIC RADIATION
    • G21H5/00Applications of radiation from radioactive sources or arrangements therefor, not otherwise provided for 
    • G21H5/02Applications of radiation from radioactive sources or arrangements therefor, not otherwise provided for  as tracers

Abstract

ISOTOPIC EXCHANGE BETWEEN RADIODINE ATOMS IN AN IODIDE SALT AND STABLE IODINE ATOMS BOUND TO AROMATIC CARBON SALT AND STABLE IODINE ATOMS BOUND TO AROMATIC AMOUNTS OF COPPER, FOR EXAMPLE, BY 2.3X10**4MG. OF CUPRIC SULFATE PER MG. OF ORGANIC COMPOUND. THE PRESENCE OF SMALL AMOUNTS OF WATER IN THE REACTION MEDIUM FURTHER ENHANCES THE EFFECT OF COPPER. NOT ONLY IS THE CONVERSION OF STBLE IODINATED COMPOUNDS TO THEIR RADIOODINATED ISO MERS SUBSTANTIALLY INCREASED IN MANY CASES, BUT ALSO LOWER TEMPERATURES AND SHORTER REACTION TIMES ARE FEASIBLE WITH LESS RISK OF DAMAGE TO HEAT-SENSITIVE ORGANIC COMPOUNDS THEREBY BROADENING THE RANGE OF USEFUL RADIOIODINATED COMPOUNDS WHICH CAN BE PREPARED BY ISOTOPE EXCHANGE. EXEMPLIFIED ARE QUINOLINES, TRYPTOPHANS, BENZOIC AND IOCETAMIC ACIDS.

Description

United States Patent Oflicc Patented June 4, 1974 3,814,769 CATALYZED RADIOIODINE EXCHANGE George B. Hoey, Ferguson, and Donald R. Peckels and Philip E. Wiegert, St. Louis, Mo., assignors to Mallmckrodt Chemical Works, St. Louis, Mo.
No Drawing. Continuation of abandoned apphcatlon Ser. No. 821,097, May 1, 1969. This application Dec. 27, 1971, Ser. No. 212,662
Int. Cl. C07d 33/36 U.S. Cl. 260-488 A 11 Claims ABSTRACT OF THE DISCLOSURE Isotopic exchange between radioiodine atoms in an iodide salt and stable iodine atoms bound to aromatic carbon atoms is accelerated by the presence of catalytic amounts of copper, for example, by 2.3x mg. of cupric sulfate per mg. of organic compound. The presence of small amounts of water in the reaction medium further enhances the effect of copper. Not only is the conversion of stable iodinated compounds to their radioiodinated isomers substantially increased in many cases, but also lower temperatures and shorter reaction times are feasible with less risk of damage to heat-sensitive organic compounds thereby broadening the range of useful radioiodinated compounds which can be prepared by isotope exchange. Exemplified are quinolines, tryptophans, benzoic and iocetarnic acids.
This is a continuation, of application Ser. No. 821,097, cfiled May 1, 1969, now abandoned.
BACKGROUND OF THE INVENTION (1) Field of the invention This invention relates to the field of radioactive organic compounds and more particularly to improved methods for preparing same.
(2) Summary of the prior art Various organic compounds containing one or more radioactive iodine atoms bound to an unsaturated cyclic carbon atom are used as tracer compounds in medical research and diagnosis. A well known example is the radioiodine analog of sodium o-iodohippurate. More recently it has been shown that the radioiodine analogs of 4 (3 dimethylaminopropylamino)-7-iodoquinoline are pared by heating a solution containing the stable iodine analog of the desired compound with a radioactive iodide such as sodium iodide. In the case of compounds where the iodine is tightly bound to carbon, as when the carbon is part of an unsaturated ring system such as a benzene ring, the exchange between stable and radioactive iodine atoms often proceeds very slowly even at elevated temperatures. As a result the yield of the desired radioiodinated compound is poor, there is excessive loss of the valuableradioisotope through natural decay, and if the reaction temperature is raised to increase the rate of exchange, appreciable thermal degradation of the organic compound may occur with further loss of valuable material.
Therefore, methods which would accelerate the exchange between stable iodine atoms and radioactive iodine atoms mentioned above and enable such exchanges to be effected at lower temperatures and/or within shorter times would be of great practical importance. Such methods would not only permit more efiicient utilization of'valuable radioisotopes, they would also permit the economical preparation of a broader range of radioiodinated compounds than has heretofore been feasible.
SUMMARY OF THE INVENTION Among the objects of the invention may be mentioned the provision of improved methods for effecting exchange between stable iodine atoms bound to an aromatic carbon atom and radioactive iodine atoms in the form of inorganic iodide salts; and the provision of such methods which may be carried out at lower temperatures and/or which require shorter reaction times than were feasible heretofore. Other objects and features of the invention will be in part apparent and in part pointed out hereinafter.
The present invention is broadly directed to methods for preparing radioiodinated organic compounds containing at least one iodine atom bound to an aromatic carbon atom which comprises combining the corresponding organic compound containing stable iodine atoms with an iodide salt containing a radioisotope of iodine and a suitable solvent therefore in the presence of a catalytic amount of copper and a time sufiicient to effect substantial exchange between the stable iodine atoms and the radioisotopic iodine atoms, and thereafter recovering the resulting radioiodinated organic compound.
With the aid of the copper catalyst, radioiodine exchange can be effected with many organic compounds within a short time even at room temperature where otherwise prolonged reaction times and/or elevated temperatures would be necessary.
Even in the case of compounds where exchange proeeeds reasonably well in the absence of a catalyst, the addition of copper is beneficial in that it permits the use of lower reaction temperatures and shorter reaction times, a particularly important consideration when working with heat-sensitive organic compounds and/or short-lived radioisotopes.
DESCRIPTION OF THE PREFERRED EMBODIMENTS The form in which the copper catalyst is added to the reaction mixture appears not to be critical. For example, it can be in the form of a small amount of copper powder or copper oxide, but it is usually more convenient to add a solution of a soluble copper salt, such as cupric sulfate, cupric chloride, cuprous, cupric nitrate, cupric acetate or other soluble copper salts known in the chemical arts.
Only very small amounts of copper are required to catalyze the exchange between the organically bound stable iodine atoms and the anionic radioactive iodine atoms. For example, as little as 4.45 10 mole of copper per gram atom of organically bound iodine has been found to be catalytically effective, while a ten-fold increase in the amount of catalyst was not appreciably more effective.
The choice of solvent depends primarily upon the solubility characteristics of .the iodinated organic compound.
If the latter compound is insoluble in water, a watermiscible solvent such as diglyme (diglycol methyl ether) is preferred, since it has been found that a small amount of water, e.g., 5% by volume of the total solvent, increases the effectiveness of the copper catalyst. However, other common organic solvents and solvent systems, whether or not miscible with water, can also be used.
EXAMPLE 1 To a Pyrex tube constructed from 9 mm. O.D. tubing was added 100 mg. of 4-(3-dimethylaminopropy1-amino)'- v 7-iodoquinoline followed by 4 ml. of diglyme that had sulfate were added. The water content of the mixture was approximately by volume based on the diglyme. The tube was sealed and heated in an oil bath at a temperature of 160 C. for 17 hours.
The tube was then cooled and the contents were poured into 25 ml. of water made basic with 0.3 ml. of concentrated ammonium hydroxide. The basic solution was extracted 4 times with a total of 25 ml. of chloroform, and the chloroform extract was then extracted 4 times with a total volume of 23 ml. of 0.1 N hydrochloric Finally, this acid extract was quantitatively transferred into a 25 ml. volumetric flask and diluted to volume with 0.1 N hydrochloric acid. Radioactivity measurement of the final solution showed that approximately 90% of the iodine-131 was incorporated in the iodine compound, allowance being made for natural decay of the radioisotope during the conversion. When the amount of cupric sulfate was reduced to 0.01 mg. the results were essentially the same, but when cupric sulfate was omitted entirely, all other conditions remaining the same, only 14.2% of the iodine-131 was incorporated in the iodinated compound.
EXAMPLE 2 The procedure described in Example 1 was modified as follows. The reaction tube was constructed from 9 mm. O.D. Vycor quartz tubing. To avoid adsorption of radioactive iodine by the quartz, the tube was pretreated with a solution of sodium bisulfite and sodium iodide as directed in the U.S. Pharmacopoeia XVII, page 800.
With these modifications the incorporation of radioactive iodide into the iodinated organic compound was essentially quantitative after 2 hours at 160 C. When copper sulfate and the pretreatment of the tube with sodium bisulfite and sodium iodide were omitted, all other conditions remaining the same, the incorporation of radio active iodine was only 32.1% after 17 hours.
EXAMPLE 3 The organic compound of Examples 1 and 2 was also radioiodinated using mesitylene as the solvent with the following modifications in technique.
The mesitylene was shaken in a separatory funnel with an aqueous solution containing 0.1 mg. cupric sulfate per 100 microliters until the mesitylene was saturated With the solution. The sodium iodide-131 was introduced as before as a solution in diglyme. When the mixture was heated in a sealed quartz tube at 160 C. the incorporation of iodine-131 was 72.3% after 17 hours whereas, if the treatment with copper sulfate solution was omitted, the incorporation was only 54.9%.
EXAMPLE 4 Copper sulfate was used as follows to catalyze the radioiodination of iothalamic acid -(5-acetamido-2,4,6- triiodo-N methylisophthalmic acid) whose structural formula is:
The exchange was carried out in an aqueous reaction mixture consisting of 1 N sodium hydroxide (150 microliters), pH 4.0 sodium acetate-acetic acid buffer (0.55 ml.), M potassium iodate (100 microliters) and water (10 microliters). Cupric sulfate (0.01 mg.) was dissolved in the water. The iothalamic acid (100 mg.) was dissolved in this solvent and to it was added a solution containing sodium iodide-131 (150 microcuries).
When the mixture was heated at 100 C. in a sealed Pyrex tube, 65.4% of iodine-131 was incorporated in the iothalamic acid after 1 hour and 85-86% was incorpo- 4 Y rated after 18 hours. Without the cupric sulfate, the incorporation was only 58.6% after 1 hour.
EXAMPLE 5 Copper also catalyzes the introduction of iodine-131 into N-acetyl-S-iodotryptophan whose structural formula ganic compound whereas, without the cupric sulfate and water, only 39% was incorporated after 17 hours.
EXAMPLE 6 The following substituted alkanoic acid, iocetamic acid, was also radioiodinated with the aid of a copper catalyst:
CH3 CHaC O-N-CHzCHI O OH NHr The reaction was carried out following the general procedure of Example 2. The reaction mixture contained 25 mg. of the above compound and approximately microcuries of sodium iodide-131 dissolved in 1 ml. of diglyme.
When the reaction mixture also contained 5% water and 4 micrograms Cu as copper sulfate (1.5 X 10- mole Cu per mole of the iodinated compound), the percentage incorporation of iodine-131 was 95.3% after 22 hours at C.
When the copper catalyst was omitted, the percentage incorporation was 87.5% after 22 hours at 160 C.
When both the water and the copper catalyst were omitted, the percentage incorporation was only 77.5% after 22 hours at 160 C.
It will be understood that the method of the invention may be applied to various other organic compounds having an iodine atom bound to an aromatic carbon atom with similar results.
.The invention accordingly comprises the methods hereinafter described, the scope of the invention being indicated in the following claims.
As various changes could be made in the above methods without departing from the scope of the invention, it is intended that all matter contained in the above description shall be interpreted as illustrative and not in a limiting sense. I
What is claimed is:
1. In an isotope exchange process for preparing an iodinated organic compound enriched in radioiodine content containing at least one iodine atom bound to an aromatic carbon atom by combining an organic compound having at least one stable iodine atom bound to an arcmatic carbon atom with an iodide salt containing a radioisotope of iodine in a solvent for said organic compound enriched in radioiodine content and thereafter recovering the resulting iodinated organic compound from the reaction mixture, the improvement which comprises incorporating a catalytic amount of copper in the reaction mixture to effect substantial exchange between the stable iodine atoms and the radioisotopic iodine atoms.
2. A method according to claim 1 wherein the organic compound is an iodinated quinoline derivative.
3. A method according to claim 1 wherein the organic compound is an iodinated benzoic acid derivative.
4. A method according to claim 1 wherein the iodide salt is an alkali metal iodide.
5. A method according to claim 1 wherein the radioisotope of iodine is iodine-131.
6. A method according to claim 1 wherein the radioisotope of iodine is iodine-125.
7. A method according to claim 1 wherein the solvent contains approximately 5% water.
8. A method according to claim 1 wherein the solvent is diglycol methyl ether.
9. A method according to claim 1 wherein the organic compound is an iodinated indole derivative.
10. A method according to claim 1 wherein at least 4.45 X 10- mole of copper per gram atom of organically bound iodine is present as the catalytic amount of copper.
11. A method as set forth in claim 7, said copper being present in the form of a water soluble copper salt.
References Cited UNITED STATES PATENTS OTHER REFERENCES Counsell et al.: Jour. Pharm. Soc. vol. 56, pp. 1042-4 (1967).
DONALD G. DAUS, Primary Examiner US. Cl. X.R.
g gg UNITED STATES PATENT OFFICE CERTIFICATE OF CORRECTION Patent No. 2 8llL76Q Dated June n. 197
Inventor(s) George B. Hoey, Donald R. Peckels and Philip E.Wiegert It is certified that error appears in the above-identified patent and that said Letters Patent are hereby corrected as shown below:
r" Column 1, second paragraph of the heading, "821,097" should read ---82l,093----.
Signed and sealed this 8th day of October 1974.
(SEAL) Attest:
MCCOY M. GIBSON JR. C. MARSHALL DANN Attesting Officer Commissioner of Patents UNITED STATES PATENT OFFICE CERTIFICATE OF CORRECTION Patent No. 398lLH769 Dated June I, 197A Inventor(s) George B. Hoey et a1.
It is certified that error appears in the above-identified patent and that said Letters Patent are hereby corrected as shown below:
Column 1, second paragraph of the heading and line 30, "821,097" should read 821,095
This certificate supersedes Certificate of Correction issued October 8, 1974.
signed and sealed this 1st day of April 1975.
(SEAL) Attest:
I-LARSHALL DANN v RUTH C. MASON Commissioner of Patents attesting Officer and Trademarks FORM PO-IOSO (IO-69) USCOMM-DC 60376-P69 LLS. GOVERNMENT PRINTING OFFICE: 8 5 930 3 3 UNITED STATES PATENT OFFICE CERTIFICATE OF CORRECTION Patent No. q 8114 76 Dated June l lQ7 I George B. Hoey, Donald R. Peckels and Philip E.Wiegert It is certified that error appears in the above-identified patent and that said Letters Patent are hereby corrected as shown below:
T Column 1, second paragraph of the heading, "821,097" should 1 A read --82l,093-.
Signed and sealed this 8th day of October 1974.
(SEAL) Attest:
McCOY M. GIBSON JR. Attesting Officer C. MARSHALL DANN Commissioner of Patents
US00212662A 1969-05-01 1971-12-27 Catalyzed radioiodine exchange Expired - Lifetime US3814769A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US00212662A US3814769A (en) 1969-05-01 1971-12-27 Catalyzed radioiodine exchange

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US82109769A 1969-05-01 1969-05-01
US86578569A 1969-10-13 1969-10-13
US00212662A US3814769A (en) 1969-05-01 1971-12-27 Catalyzed radioiodine exchange

Publications (1)

Publication Number Publication Date
US3814769A true US3814769A (en) 1974-06-04

Family

ID=27395773

Family Applications (1)

Application Number Title Priority Date Filing Date
US00212662A Expired - Lifetime US3814769A (en) 1969-05-01 1971-12-27 Catalyzed radioiodine exchange

Country Status (1)

Country Link
US (1) US3814769A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0165630A3 (en) * 1984-05-24 1986-01-08 Mallinckrodt, Inc. Method of preparing a chlorinated, brominated, radiobrominated, iodinated and/or radioiodinated, aromatic or heteroaromatic compound, as well as diagnostic composition on the basis of this compound, kit for preparing said composition, and method and equipment for the preparation of this composition
WO2001034660A2 (en) * 1999-11-09 2001-05-17 Sri International Screening and analysis of polymers, specialty chemicals and catalysts using radiography
US6602714B1 (en) 1999-11-09 2003-08-05 Sri International Viscosity and mass sensor for the high-throughput synthesis, screening and characterization of combinatorial libraries
US7033840B1 (en) 1999-11-09 2006-04-25 Sri International Reaction calorimeter and differential scanning calorimeter for the high-throughput synthesis, screening and characterization of combinatorial libraries

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0165630A3 (en) * 1984-05-24 1986-01-08 Mallinckrodt, Inc. Method of preparing a chlorinated, brominated, radiobrominated, iodinated and/or radioiodinated, aromatic or heteroaromatic compound, as well as diagnostic composition on the basis of this compound, kit for preparing said composition, and method and equipment for the preparation of this composition
AU576861B2 (en) * 1984-05-24 1988-09-08 Mallinckrodt, Inc. Halogenation of aromatic compounds
US4942231A (en) * 1984-05-24 1990-07-17 Mallinckrodt, Inc. Method of preparing a chlorinated, brominated, radio-brominated, iodinated and/or radioiodinated aromatic or heteroaromatic compound
WO2001034660A2 (en) * 1999-11-09 2001-05-17 Sri International Screening and analysis of polymers, specialty chemicals and catalysts using radiography
WO2001034660A3 (en) * 1999-11-09 2001-11-29 Stanford Res Inst Int Screening and analysis of polymers, specialty chemicals and catalysts using radiography
US6602714B1 (en) 1999-11-09 2003-08-05 Sri International Viscosity and mass sensor for the high-throughput synthesis, screening and characterization of combinatorial libraries
US7033840B1 (en) 1999-11-09 2006-04-25 Sri International Reaction calorimeter and differential scanning calorimeter for the high-throughput synthesis, screening and characterization of combinatorial libraries

Similar Documents

Publication Publication Date Title
Pike et al. Preparation of [1− 11C] acetate—An agent for the study of myocardial metabolism by positron emission tomography
Coenen et al. Preparation of nca [17‐18F]‐fluoroheptadecanoic acid in high yields via aminopolyether supported, nucleophilic fluorination
US4942231A (en) Method of preparing a chlorinated, brominated, radio-brominated, iodinated and/or radioiodinated aromatic or heteroaromatic compound
Brodack et al. NCA 16α-[18F] fluoroestradiol-17β: the effect of reaction vessel on fluorine-18 resolubilization, product yield, and effective specific activity
US4647446A (en) Rapid brain scanning radiopharmaceutical
US3814769A (en) Catalyzed radioiodine exchange
CA1257602A (en) Technetium-99m labeled dioxime complexes
Robinson Jr Synthesis of 123I-16-iodo-9-hexadecenoic acid and derivatives for use as myocardial perfusion imaging agents
Milius et al. Organoastatine chemistry. Astatination via electrophilic destannylation
US4476106A (en) Process for the extemporaneous preparation of an injectable fatty acid tagged in the omega position by means of radioactive iodine
US4284619A (en) Esters useful as brain imaging agents
US3859429A (en) M-iodohippuric acid labelled with radioactive iodine and process for its preparation
Hoey et al. Catalyzed radioiodine exchange
EP0203815B1 (en) Technetium-arene complexes and method
Maziere et al. 11 C-methiodide quinuclidinyl benzilate a muscarinic antagonist for in vivo studies of myocardial muscarinic receptors
US4350674A (en) Substituted acetanilidoiminodiacetic acid compounds, diagnostic agents containing such compounds labeled with technetium-99m, and methods for making and using such compounds and agents
Bijl et al. Hippuran-123 I: Preparation and quality control
BE899739A (en) METHOD FOR VERIFYING SUBSTITUTION ON AROMATIC NUCLEAR, AND, METHOD AND EQUIPMENT FOR PREPARING COMPOSITION FOR SCINTIGRAPHIC RESEARCH.
Berridge et al. Intramolecular Effects of125 I Decay in o-Iodotyrosine
Nunn The kinetics of incorporation of 111 In into m-tetraphenylporphine
Robien et al. Synthesis of radioiodinated metyrapone—a potential adrenal imaging agent
US4876073A (en) Radionuclide generator
US3749913A (en) Renal scanning composition and method using technetium 99m
Srivastava et al. Faciie-Radioiododemetallation Reactions for the Convenient Preparation of Raoioiodinated Compounds
Zalutsky et al. Synthesis of 11C-dl-tryptophan and its purification using high-pressure liquid chromatography

Legal Events

Date Code Title Description
AS Assignment

Owner name: MALLINCKRODT, INC.

Free format text: CHANGE OF NAME;ASSIGNOR:MALCO, INC.;REEL/FRAME:004572/0403

Effective date: 19860101

AS Assignment

Owner name: MALLINCKRODT MEDICAL, INC., 675 MCDONNELL BOULEVAR

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNOR:MALLINCKRODT, INC., A CORP. OF DE;REEL/FRAME:005635/0379

Effective date: 19910227